BASF invests $63M in PVP manufacturing operations

BASF intends to invest more than $63 million to build a polyvinylpyrrolidone (PVP) plant in Shanghai, China, as well as expanding capacity at plants in plants in Ludwigshafen, Germany, and Geismar, LA. The company said the €56 million investment will increase its capacity by about 6,000 metric tons. Release

Suggested Articles

The FDA asked five drugmakers to pull their version of extended-release metformin off U.S. shelves after finding carcinogen contamination.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.